n.a. (ABPI)

OTC Markets
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange OTC Markets
Div & Yield N.A. (N.A)

Biotech-Stock Mailbag: Genentech

More on the Roche deal for Genentech, the value in Gilead and much more.

Tuesday's Winners & Losers: Accentia Biopharmaceuticals

Shares plunge 67.6% after the company chooses to halt development of the drug SinuNase.

Monday's Health Winners & Losers

Accentia climbs on SinuNase study results.

Tuesday's Health Winners & Losers

Telik tumbles on startling results for its experimental cancer treatment Telcyta.

Monday's Small-Cap Winners & Losers

Sigma Designs and GTX trade lower on negative analyst research.

Wednesday's Health Winners & Losers

Genomic Health jumps.

Accentia Gets Drug-Study Boost

Shares soar some 59% on postive cancer remission data for BiovaxID.

Thursday's Health Winners & Losers

Accentia Biopharmaceuticals surges.

Wednesday's Health Winners & Losers

Osiris Therapeutics is stronger.

Monday's Health Winners & Losers

An upgrade lifts BioMarin.

Accentia Strikes Financing Pact

The four-year agreement is for $25 million in exchangeable convertible debentures.

Today's Health Winners and Losers

BioDelivery Sciences sinks after the FDA sends a nonapprovable letter for the nausea drug Emezine.

Health Stocks in Motion

Exact Sciences rises nearly 50%.